Toll-like receptors and NOD-like receptors in rheumatic diseases.
about
Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis PathwayPattern recognition receptors as potential therapeutic targets in inflammatory rheumatic diseaseCytokine-modulating strategies and newer cytokine targets for arthritis therapy.Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.Oral neutrophil transcriptome changes result in a pro-survival phenotype in periodontal diseasesCrystals, inflammation, and osteoarthritis.Toll-like receptors are potential therapeutic targets in rheumatoid arthritis.Innate immunity sensors participating in pathophysiology of joint diseases: a brief overview.NOD2 deficiency results in increased susceptibility to peptidoglycan-induced uveitis in miceInvestigation of the differential potentials of TLR agonists to elicit uveitis in mice.Cold and heat pattern of rheumatoid arthritis in traditional Chinese medicine: distinct molecular signatures indentified by microarray expression profiles in CD4-positive T cell.Dectin-1 and NOD2 mediate cathepsin activation in zymosan-induced arthritis in mice14-3-3ε and 14-3-3σ inhibit Toll-like receptor (TLR)-mediated proinflammatory cytokine induction.TLR4-mediated IL-12 production enhances IFN-γ and IL-1β production, which inhibits TGF-β production and promotes antibody-induced joint inflammation.Surface expression and genotypes of Toll-like receptors 2 and 4 in patients with juvenile idiopathic arthritis and systemic lupus erythematosusVitamin D deficiency impacts on expression of toll-like receptor-2 and cytokine profile: a pilot studyNegative regulation of NF-κB and its involvement in rheumatoid arthritis.Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors.Suppression of Autoimmune Arthritis by Small Molecule Inhibitors of the JAK/STAT Pathway.Fungal-derived cues promote ocular autoimmunity through a Dectin-2/Card9-mediated mechanism.Activation of human fibroblast-like synoviocytes by uric acid crystals in rheumatoid arthritis.Polyene Phosphatidylcholine inhibited the inflammatory response in LPS-stimulated macrophages and ameliorated the adjuvant-induced rat arthritisThe potential importance of Toll-like receptors in ankylosing spondylitis.Association of NLRP3 polymorphisms with susceptibility to primary gouty arthritis in a Chinese Han population.Free fatty acids: potential proinflammatory mediators in rheumatic diseases.Crosstalk of dynamic functional modules in lung development of rhesus macaques.Altered IL-10 and TNF-α production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation.
P2860
Q26771260-950C2C9E-E421-42F9-A216-8B30377A3F39Q28084262-68846488-87B4-4F97-900D-C1EBF455FE5DQ34456715-A0D86D42-A610-4E1E-98E1-4C2BFDF9FC64Q34672043-7ECDB3FB-89AA-4AD9-B296-6B544946037CQ34852269-FFAAB736-2F5B-4240-8E79-BB4EFB1BA10FQ35160318-03C1DD5D-9701-4A36-983C-6730B5FD300DQ35172878-0E57238B-209A-40C9-84F6-9898268587EAQ35206138-7279CF61-411B-49A8-9FFB-0FDF1DF2040FQ35220891-83A736B7-214B-45D8-A8BF-D27DC46921ECQ35609376-F0A1E66A-E6FB-47D6-8C35-D719C6538BC6Q35659297-545ADADD-0BEA-4BDE-B4DE-B0671BADA113Q35961407-04369E00-1BEE-4C43-9C71-43E825BEE117Q36385819-6BF3AA8B-1C10-4A1A-8855-08F6FCEAD027Q36633174-6B7E20F5-C183-48AF-B29B-B638EFF71275Q36767444-59EC4AFD-95A7-43DE-8503-A1E402CDFBEFQ37070661-55D47342-DE62-4F9A-9DA4-44D306632FADQ37884644-07C618BB-6F27-43F2-A5A6-0ED6A9ABE1A3Q38931186-82CDC0FC-562E-4058-B52E-667D79C3CAEAQ38974299-06F095BD-A8F2-41BA-80CD-B6DA1F64B5D6Q39143336-2093306A-EDCA-4B0F-AE96-301EFAA55044Q39333539-F823425E-2CA6-49DD-A024-E3B09F716D17Q42068012-7CA28B9B-B2C7-4490-B43C-85547716D48CQ42622426-2C116467-32A1-44B2-9F23-F6634EF061B7Q47795988-35CA9549-947C-45D1-A1A6-AD50D18CC223Q50139520-3CDAC283-38AC-409E-94BF-D8BC5F417547Q50530547-F6C0EC49-A72A-4B28-901F-00011F40F40DQ54349394-19E56093-2A14-41E0-B40C-A53A362F38C3
P2860
Toll-like receptors and NOD-like receptors in rheumatic diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Toll-like receptors and NOD-like receptors in rheumatic diseases.
@en
Toll-like receptors and NOD-like receptors in rheumatic diseases.
@nl
type
label
Toll-like receptors and NOD-like receptors in rheumatic diseases.
@en
Toll-like receptors and NOD-like receptors in rheumatic diseases.
@nl
prefLabel
Toll-like receptors and NOD-like receptors in rheumatic diseases.
@en
Toll-like receptors and NOD-like receptors in rheumatic diseases.
@nl
P2860
P921
P356
P1476
Toll-like receptors and NOD-like receptors in rheumatic diseases.
@en
P2093
Andrew E Parker
William J McCormack
P2860
P2888
P356
10.1186/AR2729
P577
2009-10-14T00:00:00Z
P5875
P6179
1024780219